APPLICATION
ANDA076215
TYPE
ANDA
ORIGINAL APPROVAL
2003-12-09
LATEST ACTION
2020-07-07
ROUTE
TOPICAL
DOSAGE FORM
CREAM, AUGMENTED
MARKETING STATUS
Prescription
Products
BETAMETHASONE DIPROPIONATEPrescription
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · CREAM, AUGMENTED · TOPICAL
Approval history
2020-07-07Labeling · Supplement 10 · standardAP
2020-07-07Labeling · Supplement 11 · standardAP
2016-05-12Labeling · Supplement 8 · standardAP
2006-09-29Labeling · Supplement 4AP
2003-12-09OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.